Chargement des cours...
Prévisions
L'objectif de cours moyen des analystes est de 77,63 € (+19,89 %). La médiane est de 74,21 € (+14,61 %).
| Acheter |
13 |
| Conserver |
10 |
| Vendre |
0 |
Discussions dans la communauté
Il n'y a pas encore de discussion sur cet actif.
Lancer une discussionActualités Accéder au fil d'actualités
Stifel Financial hits 52-week low at $67.95 despite strong quarterly results
Stifel Financial’s stock fell to a 52-week low of $67.95 and is currently trading near $67.89, giving it a market capitalization of about $10.45 billion. The shares have lost roughly 17.8% over six months and 16.2% year-to-date. At the same time, the company reported strong Q1 results with operating earnings per share of $1.45, revenue up 18% to $1.48 billion, assets under management of $579.7 billion and a dividend of $0.34 per share; analysts see valuation metrics suggesting undervaluation. » Plus sur de.investing.com
Stifel Financial announces quarterly dividend of $0.34
Stifel Financial declared a cash dividend of $0.34 per common share, payable on June 15, 2026 to shareholders of record on June 1, 2026. The board also confirmed quarterly dividends for three series of preferred stock (Series B, C and D) with respective distributions of approximately $0.390625, $0.3828125 and $0.28125 per depositary share. The dividend reflects the company’s nine years of rising payouts; the current yield is 1.73 percent. Investor note: the preferred dividends cover the period from March 16 to June 15, 2026. » Plus sur de.investing.com
Stifel exceeds Q1 2026 expectations on earnings and revenue, stock slightly under pressure
Stifel reports adjusted EPS of $1.45 for Q1 2026 (expectation $1.37) and revenue of $1.48bn (expectation $1.44bn), driven by strong investment banking fees. Despite the positive results, the stock fell 0.38% in pre-market trading to $81.96. Management highlights company-wide AI initiatives and venture lending as growth drivers and reaffirms a positive outlook with EPS guidance between $1.46 and $2.09 and expected Q2 revenue of about $1.47bn. Risks remain from market volatility, geopolitical tensions and interest-rate uncertainty. » Plus sur de.investing.com
Acumen Pharmaceuticals presents Sabirnetug strategy at Stifel forum
Acumen Pharmaceuticals provided a strategic overview of Sabirnetug, which targets toxic, soluble Aβ oligomers in Alzheimer’s. The phase 2 ALTITUDE‑AD study with 542 recruits was completed in 10 months; results are expected at the end of 2026 and are seen as key to validating the Aβ oligomer hypothesis. The company is collaborating with JCR Pharmaceuticals to improve brain uptake using IZCARGO and aims to file an IND for the EBD program by mid‑2027. Acumen remains open to partnerships for phase 3 development, depending on the ALTITUDE‑AD results; the subcutaneous formulation will continue to be evaluated. » Plus sur de.investing.com
Stifel Financial beats Q4-2025 forecasts, announces stock split and dividend increase
Stifel Financial reported Q4 2025 earnings per share of $2.63 (expectation $2.51) and revenue of $1.56 billion (expectation $1.5 billion). Management announced a 3-for-2 stock split and an 11% dividend increase. For 2026, net revenue is expected between $6.0 billion and $6.35 billion; 2025 was a record year with $5.5 billion. Despite the positive results, the stock moved little in premarket trading, and the company continues to show strong margins and a high return on tangible equity. » Plus sur de.investing.com
Dividendes historiques Dividendes
Tous les indicateurs de dividendes Tous les indicateursDonnées financières de l'entreprise
| (EUR) | septembre 2026 | YoY |
|---|---|---|
| Chiffre d'affaires | 1,44 Md | 4,66 % |
| Bénéfice brut | 1,25 Md | 4,15 % |
| Bénéfice net | 206,71 M | 14,77 % |
| EBITDA | 280,37 M | 7,11 % |
Données fondamentales
| Indicateur | Valeur |
|---|---|
Capitalisation boursière | 9,65 Md € |
Nombre d'actions | 149,24 M |
Plus haut/bas sur 52 semaines | 81,80 € - 59,55 € |
Rendement du dividende | 1,93 % |
Dividendes TTM | 1,27 € |
Prochain dividende | 0,31 € |
Bêta | 1,02 |
Ratio P/E | 10,25 |
Ratio PEG | 0,70 |
Ratio P/B | 1,78 |
Ratio P/S | 1,58 |
Profil de l'entreprise
Stifel Financial Corp., une société holding de services financiers et de banque, propose des services de gestion de patrimoine de détail et institutionnelle, ainsi que des services de banque d'investissement, à des investisseurs particuliers, des entreprises, des collectivités locales et des institutions aux États-Unis, au Royaume-Uni, dans le reste de l'Europe et au Canada. Elle exerce son activité à travers trois segments : Global Wealth Management, Institutional Group et Autres. La société fournit des services aux clients privés, notamment des services de transaction sur titres et de planification financière ; des activités institutionnelles de vente, de négociation et de recherche sur actions et titres à revenu fixe, ainsi que des services de financement des collectivités locales ; des services de banque d'investissement, tels que les fusions-acquisitions, les introductions en bourse et les placements privés ; ainsi que des services de banque de détail et commerciale comprenant des programmes de prêts aux particuliers et aux entreprises, ainsi que des comptes de dépôt. Elle participe également à la gestion de souscriptions pour le financement des entreprises et du secteur public, et propose des services de conseil financier et de courtage en valeurs mobilières. La société a été fondée en 1890 et son siège social se situe à St. Louis, Missouri.
| Nom | Stifel Financial Co. |
| PDG | Ronald James Kruszewski |
| Siège social | Saint Louis,
mo États-Unis |
| Site web | |
| Secteur | Finance |
| Industrie | Services financiers |
| Introduction en bourse | 19/07/1983 |
| Employés | 8 900 |
Symboles boursiers
| Bourse | Symbole |
|---|---|
NYSE | SF |
Frankfurt | 2SI.F |
Düsseldorf | 2SI.DU |